$ELMD
Electromed, Inc. Stock $elmd

$elmd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000089710123000192 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$13.61M	$12.07M	$10.14M
YoY Change	20.79%	19.0%	15.41%
Cost Of Revenue	$3.162M	$3.012M	$2.398M
YoY Change	0.35%	25.6%	14.96%
Gross Profit	$10.45M	$9.056M	$7.743M
YoY Change	28.73%	16.96%	15.55%
Gross Profit Margin	76.77%	75.04%	76.35%
Selling, General & Admin	$8.658M	$7.694M	$6.544M
YoY Change	18.47%	17.57%	8.15%
% of Gross Profit	82.85%	84.96%	84.52%
Research & Development	$298.0K	$166.0K	$336.0K
YoY Change	-5.4%	-50.6%	-17.44%
% of Gross Profit	2.85%	1.83%	4.34%
Depreciation & Amortization	$191.0K	$103.0K	$173.0K
YoY Change	23.23%	-40.46%	20.98%
% of Gross Profit	1.83%	1.14%	2.23%
Operating Expenses	$8.956M	$7.860M	$6.880M
YoY Change	17.49%	14.24%	6.53%
Operating Profit	$1.494M	$1.196M	$863.0K
YoY Change	201.82%	38.59%	255.14%
Interest Expense	$41.00K	$26.00K	$6.000K
YoY Change	925.0%	333.33%	-40.0%
% of Operating Profit	2.74%	2.17%	0.7%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.535M	$1.222M	$869.0K
YoY Change	207.62%	40.62%	243.48%
Income Tax	$502.0K	$147.0K	$224.0K
% Of Pretax Income	32.7%	12.03%	25.78%
Net Earnings	$1.033M	$1.075M	$645.0K
YoY Change	169.71%	66.67%	187.95%
Net Earnings / Revenue	7.59%	8.91%	6.36%
Basic Earnings Per Share		$0.13	$0.08
Diluted Earnings Per Share	$0.12	$0.12	$73.76K
COMMON SHARES
Basic Shares Outstanding	8.561M shares	8.514M shares	8.455M shares
Diluted Shares Outstanding		8.710M shares	8.745M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.372M	$6.776M	$9.844M
YoY Change	-9.58%	-31.17%	-21.25%
Cash & Equivalents	$7.372M	$6.776M	$9.844M
Short-Term Investments
Other Short-Term Assets	$1.577M	$1.808M	$991.0K
YoY Change	-15.67%	82.44%	105.01%
Inventory	$4.221M	$3.451M	$2.089M
Prepaid Expenses
Receivables	$24.13M	$22.35M	$19.91M
Other Receivables	$0.00	$219.0K	$155.0K
Total Short-Term Assets	$37.79M	$35.17M	$32.99M
YoY Change	9.4%	6.61%	2.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.672M	$5.502M	$4.309M
YoY Change	24.17%	27.69%	22.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$161.0K	$60.00K	$1.111M
YoY Change	34.17%	-94.6%	47.54%
Total Long-Term Assets	$8.019M	$7.672M	$6.031M
YoY Change	17.49%	27.21%	23.53%
TOTAL ASSETS
Total Short-Term Assets	$37.79M	$35.17M	$32.99M
Total Long-Term Assets	$8.019M	$7.672M	$6.031M
Total Assets	$45.81M	$42.84M	$39.02M
YoY Change	10.74%	9.8%	4.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.372M	$1.289M	$1.163M
YoY Change	8.8%	10.83%	13.62%
Accrued Expenses	$4.967M	$3.795M	$2.865M
YoY Change	8.4%	32.46%	17.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.053M	$6.417M	$4.966M
YoY Change	12.63%	29.22%	17.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$86.00K	$30.00K	$43.00K
YoY Change	109.76%	-30.23%	-27.97%
Total Long-Term Liabilities	$86.00K	$30.00K	$43.00K
YoY Change	109.76%	-30.23%	-27.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.053M	$6.417M	$4.966M
Total Long-Term Liabilities	$86.00K	$30.00K	$43.00K
Total Liabilities	$8.139M	$6.447M	$5.009M
YoY Change	13.18%	28.71%	16.54%
SHAREHOLDERS EQUITY
Retained Earnings	$18.79M	$17.76M
YoY Change	19.09%
Common Stock	$86.00K	$86.00K
YoY Change	1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.67M	$36.39M	$34.01M
YoY Change
Total Liabilities & Shareholders Equity	$45.81M	$42.84M	$39.02M
YoY Change	10.74%	9.8%	4.97%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$1.033M	$1.075M	$645.0K
YoY Change	169.71%	66.67%	187.95%
Depreciation, Depletion And Amortization	$191.0K	$103.0K	$173.0K
YoY Change	23.23%	-40.46%	20.98%
Cash From Operating Activities	$999.0K	$646.0K	$159.0K
YoY Change	-235.18%	306.29%	-80.91%
INVESTING ACTIVITIES
Capital Expenditures	$441.0K	$558.0K	-$486.0K
YoY Change	-196.08%	-214.81%	659.38%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$441.0K	-$558.0K	-$486.0K
YoY Change	-3.92%	14.81%	659.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$299.0K
YoY Change			2618.18%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	38.00K	-221.0K	-299.0K
YoY Change	-107.71%	-26.09%	2618.18%
NET CHANGE
Cash From Operating Activities	999.0K	646.0K	159.0K
Cash From Investing Activities	-441.0K	-558.0K	-486.0K
Cash From Financing Activities	38.00K	-221.0K	-299.0K
Net Change In Cash	596.0K	-133.0K	-626.0K
YoY Change	-135.25%	-78.75%	-182.59%
FREE CASH FLOW
Cash From Operating Activities	$999.0K	$646.0K	$159.0K
Capital Expenditures	$441.0K	$558.0K	-$486.0K
Free Cash Flow	$558.0K	$88.00K	$645.0K
YoY Change	-299.29%	-86.36%	-28.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001488917
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable		usd
	elmd	Lease Assets Obtained In Exchange For New Operating Lease Liabilities LeaseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-34839
	dei	Entity Registrant Name EntityRegistrantName	Electromed, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1732920
	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Sixth Avenue NW
	dei	Entity Address City Or Town EntityAddressCityOrTown	New Prague
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	56071
	dei	City Area Code CityAreaCode	952
	dei	Local Phone Number LocalPhoneNumber	758-9299
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	ELMD
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8561100	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6776000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8153000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22345000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21052000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	570000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	286000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3451000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	3178000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1808000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1870000	usd
CY2023Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	219000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	35169000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	34539000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5502000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4568000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	604000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	599000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	120000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1506000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1538000	usd
CY2023Q1	us-gaap	Assets Assets	42841000	usd
CY2022Q2	us-gaap	Assets Assets	41364000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1289000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1261000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2082000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2742000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	51000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1333000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1256000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1713000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1840000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6417000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7150000	usd
CY2023Q1	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	30000	usd
CY2022Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	41000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6447000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7191000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8556600	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8556600	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8475438	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8475438	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	86000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	85000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18548000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18308000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	17760000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15780000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	36394000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	34173000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42841000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41364000	usd
CY2023Q1	us-gaap	Revenues Revenues	12068000	usd
CY2022Q1	us-gaap	Revenues Revenues	10141000	usd
	us-gaap	Revenues Revenues	34455000	usd
	us-gaap	Revenues Revenues	30390000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3012000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2398000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8386000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7066000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	9056000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	7743000	usd
	us-gaap	Gross Profit GrossProfit	26069000	usd
	us-gaap	Gross Profit GrossProfit	23324000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7694000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6544000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22937000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19806000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	166000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	336000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	618000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1041000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	7860000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	6880000	usd
	us-gaap	Operating Expenses OperatingExpenses	23555000	usd
	us-gaap	Operating Expenses OperatingExpenses	20847000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1196000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	863000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2514000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2477000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	37000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1222000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	869000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2551000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2498000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	224000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	418000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	576000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1075000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	645000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2133000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1922000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8461531	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8454504	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8449623	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8485856	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8710106	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8744535	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8694407	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8762963	shares
	us-gaap	Net Income Loss NetIncomeLoss	2133000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1922000	usd
	us-gaap	Depreciation Depreciation	370000	usd
	us-gaap	Depreciation Depreciation	368000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	105000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	506000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	703000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	32000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1293000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2582000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	284000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-98000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	264000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-105000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	519000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-270000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-443000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-111000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	550000	usd
	elmd	Accrued Compensation AccruedCompensation	660000	usd
	elmd	Accrued Compensation AccruedCompensation	173000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	316000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	53000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1221000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	980000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	54000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	86000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1275000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1066000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	40000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	305000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	70000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	962000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-418000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1032000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1377000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2045000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8153000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11889000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6776000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9844000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	655000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1003000	usd
	elmd	Property And Equipment Acquisitions In Accounts Payable PropertyAndEquipmentAcquisitionsInAccountsPayable	136000	usd
	elmd	Property And Equipment Acquisitions In Accounts Payable PropertyAndEquipmentAcquisitionsInAccountsPayable	85000	usd
	elmd	Intangible Asset Acquisitions In Accounts Payable IntangibleAssetAcquisitionsInAccountsPayable	6000	usd
	elmd	Intangible Asset Acquisitions In Accounts Payable IntangibleAssetAcquisitionsInAccountsPayable	9000	usd
	elmd	Lease Assets Obtained In Exchange For New Operating Lease Liabilities LeaseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	107000	usd
	elmd	Demonstration Equipment Returned To Inventory DemonstrationEquipmentReturnedToInventory	9000	usd
	elmd	Demonstration Equipment Returned To Inventory DemonstrationEquipmentReturnedToInventory	17000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	32416000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	439000	usd
CY2021Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-64000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	191000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	33041000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	838000	usd
CY2021Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-6000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	277000	usd
CY2021Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	663000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	33487000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	645000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	326000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	299000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34010000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	34173000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	81000	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-60000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	95000	usd
CY2022Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	145000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	34144000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	977000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	221000	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	35350000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1075000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-245000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	190000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	36394000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zAIyugA5IAf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><b><span id="xdx_86C_zwAGO7ZjAZg2">Use of estimates.</span> </b>Management uses estimates and assumptions in preparing the unaudited Condensed Financial Statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used. The Company believes the critical accounting policies that require the most significant assumptions and judgments in the preparation of its unaudited Condensed Financial Statements include revenue recognition and the related estimation of variable consideration, inventory valuation, share-based compensation and warranty reserve.</p>
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1256000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	179992	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	102435	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200140	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	112427	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12068000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10141000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34455000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30390000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	286000	usd
CY2021Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	393000	usd
	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-1107000	usd
CY2022	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-833000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1372000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	784000	usd
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	19000	usd
CY2022	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	-58000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	570000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	286000	usd
CY2023Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	2908000	usd
CY2022Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2672000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	213000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	100000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	280000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	469000	usd
CY2023Q1	us-gaap	Other Inventory In Transit OtherInventoryInTransit	263000	usd
CY2022Q2	us-gaap	Other Inventory In Transit OtherInventoryInTransit	228000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	213000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	291000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3451000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	3178000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1256000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	940000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	290000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	494000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	213000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	178000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1333000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	418000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.120	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.164	pure
CY2023Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	176000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	219000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	224000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	576000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.231	pure
CY2022Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	22000	usd
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	43000	usd
	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0100	pure
CY2023Q1	elmd	Debt Instrument Covenant Compliance Amount DebtInstrumentCovenantComplianceAmount	10125000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	239995	shares
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2725000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	506000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	703000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	502084	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	104325	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.93
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	90351	shares
	elmd	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExerciseDateFairValue	1.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	47930	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	11.19
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	468128	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.96
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0288	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0423	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0089	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0252	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.53	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.54	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.55	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.64	pure

Files In Submission

Name	View Source	Status
elmd-20230331_pre.xml	Edgar Link	unprocessable
elmd-20230331_def.xml	Edgar Link	unprocessable
0000897101-23-000192-index-headers.html	Edgar Link	pending
0000897101-23-000192-index.html	Edgar Link	pending
0000897101-23-000192.txt	Edgar Link	pending
0000897101-23-000192-xbrl.zip	Edgar Link	pending
elmd-20230331.xsd	Edgar Link	pending
elmd230506_10q.htm	Edgar Link	pending
elmd230506_ex31-1.htm	Edgar Link	pending
elmd230506_ex31-2.htm	Edgar Link	pending
elmd230506_ex32-1.htm	Edgar Link	pending
elmd230506_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
elmd-20230331_cal.xml	Edgar Link	unprocessable
elmd-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
elmd230506_10q_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELMD
Electromed, Inc. Stock $elmd

2023 Q2 Form 10-Q Financial Statement

#000089710123000192 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELMD Electromed, Inc. Stock $elmd

2023 Q2 Form 10-Q Financial Statement

#000089710123000192 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELMD
Electromed, Inc. Stock $elmd